Skip to main content

Table 3 Baseline features of the participants with diabetes mellitus

From: One-year outcomes of polymer-free amphilimus-eluting stents versus durable polymer zotarolimus-eluting stents in patients with diabetes mellitus: a meta-analysis

Studies

Mean age (years)

Males (%)

Smoker (%)

HTN (%)

DYS (%)

 

AES/ZES

AES/ZES

AES/ZES

AES/ZES

AES/ZES

Hemert 2020

65.9/67.1

73.5/73.9

24.5/18.3

70.2/72.5

61.6/58.2

Romaguera 2022

68.6/67.2

76.6/74.5

18.9/24.4

84.1/82.9

82.8/80.0

Rozemeijer 2017

69.2/68.8

74.1/82.4

25.9/35.0

96.5/91.9

90.6/91.9

Rozemeijer 2018

66.5/66.8

72.9/64.5

34.3/39.6

59.6/57.1

42.0/40.3

  1. HTN Hypertension, DYS Dyslipidemia, AES Polymer-free amphilimus-eluting stents, ZES Durable polymer zotarolimus eluting stents